Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02620683Completed
Randomised, double-blind trial of lidocaine, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Lidocaine Blood Levels 30 Minutes Post Injection at 30 months. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02620683.